• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肾移植后 BK 病毒感染及结局。

BK virus infection and outcome following kidney transplantation in childhood.

机构信息

Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.

Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.

出版信息

Sci Rep. 2021 Jan 28;11(1):2468. doi: 10.1038/s41598-021-82160-0.

DOI:10.1038/s41598-021-82160-0
PMID:33510329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7844021/
Abstract

BK virus associated nephropathy (BKN) is an important cause of kidney allograft failure. In a cohort of paediatric kidney transplant recipients, we aimed to understand the incidence and clinical outcome associated with BKN, as well as identify risk factors for BKN and BK viraemia development. We retrospectively analysed all patients who received a kidney transplant and received follow up care in our centre between 2009-2019. Among 106 patients included in the study (mean follow up 4.5 years), 32/106 (30.2%) patients experienced BK viraemia. The incidence of BKN was 7/106 (6.6%). The median time of BK viraemia development post-transplant was 279.5 days compared to 90.0 days for BKN. Development of BKN was associated with younger age at transplantation (p = 0.013). Development of BK viraemia was associated with negative recipient serology for cytomegalovirus (CMV) at time of transplantation (p = 0.012) and a higher net level of immunosuppression (p = 0.039). There was no difference in graft function at latest follow up between those who experienced BKN and those without BKN. This study demonstrates that BK virus infection is associated with younger age at transplantation, CMV negative recipient serostatus and higher levels of immunosuppression. Judicious monitoring of BK viraemia in paediatric transplant recipients, coupled with timely clinical intervention can result in similar long-term outcomes for BKN patients compared to controls.

摘要

BK 病毒相关性肾病(BKN)是导致肾移植失败的重要原因。在一组儿科肾移植受者中,我们旨在了解 BKN 相关的发病率和临床结局,以及确定 BKN 和 BK 病毒血症发展的危险因素。我们回顾性分析了 2009 年至 2019 年期间在我们中心接受肾移植并接受随访的所有患者。在纳入研究的 106 例患者中(平均随访 4.5 年),32/106(30.2%)例患者发生 BK 病毒血症。BKN 的发病率为 7/106(6.6%)。移植后发生 BK 病毒血症的中位时间为 279.5 天,而 BKN 为 90.0 天。BKN 的发展与移植时年龄较小(p=0.013)相关。BK 病毒血症的发生与移植时受者巨细胞病毒(CMV)血清学阴性(p=0.012)和更高的免疫抑制净水平(p=0.039)相关。在最新随访时,发生 BKN 与未发生 BKN 的患者的移植物功能无差异。本研究表明,BK 病毒感染与移植时年龄较小、CMV 受者血清阴性和更高水平的免疫抑制相关。在儿科移植受者中,对 BK 病毒血症进行谨慎监测,并及时进行临床干预,可以使 BKN 患者与对照组获得相似的长期结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/7844021/96cc8a80c90f/41598_2021_82160_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/7844021/54a1abf91662/41598_2021_82160_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/7844021/912b07514e14/41598_2021_82160_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/7844021/812126c8cf4b/41598_2021_82160_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/7844021/96cc8a80c90f/41598_2021_82160_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/7844021/54a1abf91662/41598_2021_82160_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/7844021/912b07514e14/41598_2021_82160_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/7844021/812126c8cf4b/41598_2021_82160_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/7844021/96cc8a80c90f/41598_2021_82160_Fig4_HTML.jpg

相似文献

1
BK virus infection and outcome following kidney transplantation in childhood.儿童肾移植后 BK 病毒感染及结局。
Sci Rep. 2021 Jan 28;11(1):2468. doi: 10.1038/s41598-021-82160-0.
2
De novo donor-specific antibody following BK nephropathy: The incidence and association with antibody-mediated rejection.BK 肾病后新出现的供体特异性抗体:发生率及与抗体介导的排斥反应的关系。
Clin Transplant. 2018 Mar;32(3):e13194. doi: 10.1111/ctr.13194. Epub 2018 Feb 11.
3
Dual positivity of donor and recipient plasma for BK virus confers a high risk for development of bk nephropathy in renal allograft.供体和受体血浆中BK病毒双阳性会使肾移植受者发生BK肾病的风险很高。
Transplant Proc. 2012 Apr;44(3):717-20. doi: 10.1016/j.transproceed.2011.11.054.
4
Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.肾移植受者在接受显著BK多瘤病毒感染或BK多瘤病毒相关性肾病治疗后的第一年随访期后肾功能的稳定情况。
Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12681. Epub 2017 Apr 17.
5
BK viremia is not associated with adverse outcomes in the absence of BK nephropathy.BK 病毒血症在无 BK 肾病的情况下与不良结局无关。
Clin Transplant. 2018 Jul;32(7):e13283. doi: 10.1111/ctr.13283. Epub 2018 Jun 15.
6
BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.肾移植后BK多瘤病毒感染:资源匮乏环境下的监测
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12770. Epub 2017 Oct 25.
7
Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update.免疫抑制剂作为 BK 病毒肾病的危险因素:综述与更新。
Expert Opin Drug Saf. 2010 Nov;9(6):959-69. doi: 10.1517/14740338.2010.495714.
8
Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.肾胰联合移植后从他克莫司-霉酚酸酯转换为他克莫司-mTOR 免疫抑制可降低 BK 和 CMV 病毒血症的发生率。
Clin Transplant. 2018 Jun;32(6):e13265. doi: 10.1111/ctr.13265. Epub 2018 May 12.
9
Which is more nephrotoxic for kidney transplants: BK nephropathy or rejection?对于肾移植来说,哪种情况更具肾毒性:BK 肾病还是排斥反应?
Clin Transplant. 2018 Apr;32(4):e13216. doi: 10.1111/ctr.13216. Epub 2018 Feb 23.
10
BK virus nephropathy in renal transplant patients in London.伦敦肾移植患者中的BK病毒肾病
Transplantation. 2008 Apr 15;85(7):1008-15. doi: 10.1097/TP.0b013e31816a32fc.

引用本文的文献

1
Native BK Viral Nephropathy After Pediatric Heart Transplantation Treated With Bilateral Native Nephrectomy and Living Donor Kidney Transplantation: A Case Report.小儿心脏移植术后原发性BK病毒性肾病行双侧自体肾切除术及活体供肾肾移植术:一例报告
Pediatr Transplant. 2025 May;29(3):e14863. doi: 10.1111/petr.14863.
2
Long-Term Clinical Outcomes of Paediatric Kidney Transplantation in Hong Kong-A Territory-Wide Study.香港儿童肾移植的长期临床结果——一项全港范围的研究
Nephrology (Carlton). 2025 Mar;30(3):e70009. doi: 10.1111/nep.70009.
3
Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejection.

本文引用的文献

1
Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy.巨细胞病毒预防策略与 BK 多瘤病毒血症和肾病的风险。
Am J Transplant. 2019 Sep;19(9):2457-2467. doi: 10.1111/ajt.15507. Epub 2019 Jul 9.
2
Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.儿科肾移植受者 BK 多瘤病毒复制和肾病的流行病学及危险因素:一项国际 CERTAIN 登记研究。
Transplantation. 2019 Jun;103(6):1224-1233. doi: 10.1097/TP.0000000000002414.
3
Antiviral treatment of BK virus viremia after kidney transplantation.
基于供体游离DNA的液体活检用于确定未来肾移植排斥反应。
Kidney Res Clin Pract. 2025 Sep;44(5):705-725. doi: 10.23876/j.krcp.23.286. Epub 2024 Sep 13.
4
Risk factors and outcome of BK polyomavirus infection in pediatric kidney transplantation.儿童肾移植中 BK 多瘤病毒感染的危险因素和结果。
Pediatr Nephrol. 2024 Dec;39(12):3559-3567. doi: 10.1007/s00467-024-06473-8. Epub 2024 Aug 1.
5
BK polyomavirus: latency, reactivation, diseases and tumorigenesis.BK 多瘤病毒:潜伏、激活、疾病和肿瘤发生。
Front Cell Infect Microbiol. 2023 Sep 13;13:1263983. doi: 10.3389/fcimb.2023.1263983. eCollection 2023.
6
A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients.小儿实体器官移植受者病毒性传染病管理的快速算法综述
Front Pediatr. 2023 Sep 4;11:1252495. doi: 10.3389/fped.2023.1252495. eCollection 2023.
7
Recurrent C3 Glomerulonephritis along with BK-Virus-Associated Nephropathy after Kidney Transplantation: A Case Report.移植肾后复发 C3 肾小球肾炎合并 BK 病毒相关性肾病:病例报告。
Medicina (Kaunas). 2023 Jul 14;59(7):1308. doi: 10.3390/medicina59071308.
8
In silico design and evaluation of a novel mRNA vaccine against BK virus: a reverse vaccinology approach.基于反向疫苗学的新型 BK 病毒 mRNA 疫苗的设计与评价。
Immunol Res. 2023 Jun;71(3):422-441. doi: 10.1007/s12026-022-09351-3. Epub 2022 Dec 29.
肾移植后BK病毒血症的抗病毒治疗。
Am J Health Syst Pharm. 2017 Dec 15;74(24):2037-2045. doi: 10.2146/ajhp160585.
4
Cytomegalovirus Seroprevalence Among Children and Adolescents in Germany: Data From the German Health Interview and Examination Survey for Children and Adolescents (KiGGS), 2003-2006.巨细胞病毒在德国儿童和青少年中的血清流行率:来自德国儿童和青少年健康访谈和体检调查(KiGGS)的数据,2003-2006 年。
Open Forum Infect Dis. 2015 Dec 9;3(1):ofv193. doi: 10.1093/ofid/ofv193. eCollection 2016 Jan.
5
Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial.左氧氟沙星治疗 BK 病毒血症的疗效:一项多中心、双盲、随机、安慰剂对照试验。
Clin J Am Soc Nephrol. 2014 Mar;9(3):583-9. doi: 10.2215/CJN.04230413. Epub 2014 Jan 30.
6
Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study.儿科肾移植受者 Epstein-Barr 病毒感染的流行病学和发病情况:一项多中心前瞻性研究。
Clin Infect Dis. 2013 Jan;56(1):84-92. doi: 10.1093/cid/cis823. Epub 2012 Oct 5.
7
Taxonomical developments in the family Polyomaviridae.多瘤病毒科的分类学进展。
Arch Virol. 2011 Sep;156(9):1627-34. doi: 10.1007/s00705-011-1008-x. Epub 2011 May 12.
8
A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study.一项评估早期类固醇撤药对儿科肾移植患儿生长影响的随机试验:TWIST 研究。
Am J Transplant. 2010 Apr;10(4):828-836. doi: 10.1111/j.1600-6143.2010.03047.x.
9
BK virus in solid organ transplant recipients.实体器官移植受者中的BK病毒
Am J Transplant. 2009 Dec;9 Suppl 4:S136-46. doi: 10.1111/j.1600-6143.2009.02904.x.
10
Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors.400名健康献血者中多瘤病毒BK和JC感染及复制的患病率
J Infect Dis. 2009 Mar 15;199(6):837-46. doi: 10.1086/597126.